Compagnie d'Entreprises CFE SA (LON:0O2T)

Checkpoint Therapeutics Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	23.96	22.78	229.41	150.01	64.02
Depreciation & Amortization	21.83	21.35	20.87	20.22	19.67
Loss (Gain) From Sale of Assets	-1.2	-0.93	-2.92	-2.1	-1.34
Asset Writedown & Restructuring Costs	-2.01	-4.72	-2.04	8.1	-0.1
Loss (Gain) on Equity Investments	17.45	16.12	13.64	7.94	-
Other Operating Activities	-8.2	-7.61	-198.17	-120.03	-31.49
Change in Accounts Receivable	59.14	3.49	-40.9	-22.87	1.51
Change in Inventory	15.41	-12.62	-8.56	-12.99	-30.39
Change in Accounts Payable	-38.09	37.61	58.57	5.82	-5.37
Change in Other Net Operating Assets	-2.99	-75.21	-	-	-
Operating Cash Flow	85.31	0.25	69.89	34.09	418.33
Operating Cash Flow Growth	34159.04%	-99.64%	105.03%	-91.85%	-5.77%
Capital Expenditures	-10.85	-19.7	-18.57	-14.56	-12.32
Sale of Property, Plant & Equipment	2.35	3.01	2.91	3.37	3.78
Cash Acquisitions	-	-	-	-2.24	-
Divestitures	0.55	-	8.2	-	0.06
Investment in Securities	2.77	-1.55	-	-5.75	-
Other Investing Activities	-3.27	7.2	-15.66	1.37	-150.9
Investing Cash Flow	-8.45	-11.04	-23.13	-17.81	-159.39
Long-Term Debt Issued	44.6	86.33	15.01	33.48	40.98
Long-Term Debt Repaid	-92.24	-38	-104.82	-33.51	-36.31
Net Debt Issued (Repaid)	-47.64	48.33	-89.81	-0.03	4.66
Repurchase of Common Stock	-	-0.84	-11.69	-	-
Common Dividends Paid	-9.92	-9.97	-	-4.89	-
Other Financing Activities	-0.49	-2.05	38.92	-5.33	-109.51
Financing Cash Flow	-58.05	35.48	-62.57	-10.25	-104.85
Foreign Exchange Rate Adjustments	0.61	2.25	-0.64	-0.2	-6.61
Net Cash Flow	19.42	26.94	-16.44	5.83	147.49
Free Cash Flow	74.46	-19.45	51.32	19.53	406.01
Free Cash Flow Growth	-	-	162.75%	-95.19%	-
Free Cash Flow Margin	6.30%	-1.56%	4.34%	1.74%	39.55%
Free Cash Flow Per Share	3.00	-0.78	2.05	0.77	16.04
Cash Interest Paid	15.39	11.04	6.08	6.77	6.46
Cash Income Tax Paid	12.86	8.38	9.66	13.22	7.2
Levered Free Cash Flow	53.63	31.85	1,874	-2,386	133.22
Unlevered Free Cash Flow	63.25	38.75	1,878	-2,382	137.26
Change in Net Working Capital	-36.91	-31.12	-1,851	2,417	-113.49

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.